{"pageContent": "Objectives: To use a contingent valuation method to compare the willingness of well-informed and ill-informed men to pay for PSA screening. Prostate cancer screening by analysis of prostate-specific antigen (PSA) levels has recently been confirmed to reduce prostate cancer death. However, PSA screening is associated with considerable risks, and men should be well informed about the risks before deciding to undergo the test.", "metaData": {"source": "Agreement between prostate cancer patients and their clinicians about utilities and attribute importance\nhttps://pubmed.ncbi.nlm.nih.gov/15117386/"}}